Aytu BiopharmaAYTU
13F holders, Q3 2024 (September 30)24holders −3
0new positions
3sold out
1famous investor
$2.35avg. 13F price*
At the end of Q3 2024, 24 institutions reported holding Aytu Biopharma Inc. (AYTU) in their 13F filings, down 3 from Q2 2024. 0 opened new positions and 3 sold out. The largest holders were Nantahala Capital Management, LLC ($2.6M), Stonepine Capital Management, LLC ($1.2M) and Armistice Capital, LLC ($555K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aytu Biopharma Inc.
- CUSIP
- 054754858
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $74K |
All 13F filers, Q2 2024 → Q3 2024: 38,278 shares bought and 43,754 shares sold, net −5,476 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Nantahala Capital Management, LLC | 0.21% | No change | 1,086,812 | $2.6M |
| Stonepine Capital Management, LLC | 0.74% | Add +6.0% | 500,958 | $1.2M |
| Armistice Capital, LLC | 0.01% | Reduce -6.3% | 236,000 | $555K |
| Renaissance Technologies | 0.00% | Add +0.8% | 74,723 | $176K |
| Geode Capital Management, LLC | 0.00% | Add +25.6% | 45,102 | $106K |
| Vanguard Group Inc. | 0.00% | No change | 27,888 | $66K |
| BlackRock, Inc. | 0.00% | — | 22,793 | $54K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -7.3% | 21,832 | $51K |
| Northern Trust Corp. | 0.00% | No change | 14,557 | $34K |
| Acadian Asset Management LLC | 0.00% | No change | 14,622 | $34K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -24.9% | 1,473 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -42.0% | 313 | $736 |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $705 |
| Morgan Stanley | 0.00% | Reduce -34.1% | 290 | $681 |
| UBS Group AG | 0.00% | Reduce -15.6% | 260 | $611 |
| Wells Fargo & Company | 0.00% | No change | 124 | $291 |
| Bank of America Corp. | 0.00% | Add +6.5% | 98 | $231 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 83 | $195 |
| Group One Trading LLC | 0.00% | No change | 37 | $87 |
| NewEdge Advisors, LLC | 0.00% | No change | 21 | $49 |
| SJS Investment Consulting Inc. | 0.00% | No change | 5 | $12 |
| CarsonAllaria Wealth Management, Ltd. | 0.00% | No change | 5 | $12 |
| US Bancorp \de | 0.00% | Reduce -66.7% | 3 | $7 |
| Tsfg, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AYTU's weight in each manager's 13F, not the share of Aytu Biopharma Inc. the manager owns.